Kenneth P. Greenberg

Chief Executive Officer at SonoThera, Inc.

Health Technology

Profile

Kenneth P.
Greenberg is the founder of Oncorus, Inc. (founded in 2015) and CODA Biotherapeutics, Inc. (founded in 2014).
Dr. Greenberg is also the founder of SonoThera, Inc.

Kenneth P. Greenberg active positions

Companies	Position	Start
SonoThera, Inc. SonoThera, Inc. Pharmaceuticals: OtherHealth Technology SonoThera, Inc. is a biotechnology company founded by Michael H. Davidson, Kenneth P. Greenberg, and Steve Feinstein. The company is based in South San Francisco, CA. The company is dedicated to treating the root cause of human disease through genetic therapy. SonoThera is developing an ultrasound-guided, nonviral gene therapy platform and treatments designed to provide patients with the next generation of safe and effective genetic medicines. The platform utilizes sonoporation, a microbubble-mediated biophysical process to non-invasively deliver genetic payloads selectively targeting a wide range of organs within the body. Kenneth P. Greenberg has been the CEO since incorporation.	Chief Executive Officer	-

All active positions of Kenneth P. Greenberg

Former positions of Kenneth P. Greenberg

Companies	Position	End
CODA Biotherapeutics, Inc. CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology CODA Biotherapeutics, Inc. engages in the development of chemo genetic neuromodulation platform for the treatment of severe neurological disorders. The company was founded by Mitchell H. Finer, Allan Basbaum, Nicholas Boulis, Joseph Glorioso III and Kenneth P. Greenberg in 2014 and is headquartered in South San Francisco, CA.	Founder	-
ONCORUS, INC.	Founder	-

See the detail of Kenneth P. Greenberg's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kenneth P. Greenberg's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
ONCORUS, INC.	Health Technology

Private companies	2
CODA Biotherapeutics, Inc. CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology CODA Biotherapeutics, Inc. engages in the development of chemo genetic neuromodulation platform for the treatment of severe neurological disorders. The company was founded by Mitchell H. Finer, Allan Basbaum, Nicholas Boulis, Joseph Glorioso III and Kenneth P. Greenberg in 2014 and is headquartered in South San Francisco, CA.	Health Technology
SonoThera, Inc. SonoThera, Inc. Pharmaceuticals: OtherHealth Technology SonoThera, Inc. is a biotechnology company founded by Michael H. Davidson, Kenneth P. Greenberg, and Steve Feinstein. The company is based in South San Francisco, CA. The company is dedicated to treating the root cause of human disease through genetic therapy. SonoThera is developing an ultrasound-guided, nonviral gene therapy platform and treatments designed to provide patients with the next generation of safe and effective genetic medicines. The platform utilizes sonoporation, a microbubble-mediated biophysical process to non-invasively deliver genetic payloads selectively targeting a wide range of organs within the body. Kenneth P. Greenberg has been the CEO since incorporation.	Health Technology